首页> 外国专利> INCREASED AMORPHOUS STABILITY OF POORLY WATER SOLUBLE DRUGS BY NANOSIZING

INCREASED AMORPHOUS STABILITY OF POORLY WATER SOLUBLE DRUGS BY NANOSIZING

机译:纳米化提高水溶性弱药物的非晶态稳定性

摘要

Disclosed is a population of nanoparticles, together with methods of making a population of nanoparticles, wherein one or more of the nanoparticles includes: an amorphous drug core having an effective diameter less than or equal to about 2.0 microns, wherein the amorphous drug core is substantially free of dopant, and wherein the amorphous drug core comprises a drug with properties that satisfy the following relationships: a glass transition temperature greater than or equal to about 30 Deg. C.; and water solubility at 25 Deg. C. less than or equal to about 1 mg/ml; and at least one stabilizer adsorbed on a surface of the amorphous drug core; and wherein the at least one stabilizer is present in an amount effective to provide an amorphous stability of the population of nanoparticles that is approximately equal to or greater than an amorphous stability of an amorphous bulk drug substance comprising the drug, as measured over a period of at least four months.
机译:公开了一种纳米颗粒群,以及制备纳米颗粒群的方法,其中一个或多个纳米颗粒包括:有效直径小于或等于约2.0微米的无定形药物核心,其中所述无定形药物核心基本上是不含掺杂剂,并且其中无定形药物核心包含具有满足以下关系的性质的药物:玻璃化转变温度大于或等于约30度。 C。;和25度的水溶性。 C.小于或等于约1mg / ml;至少一种稳定剂吸附在无定形药物核心的表面上;并且其中至少一种稳定剂的存在量有效地提供了纳米颗粒群体的非晶态稳定性,该非晶态稳定性大约等于或大于包含该药物的非晶态大宗药物物质的非晶态稳定性,在一段时间内测量至少四个月。

著录项

  • 公开/公告号US2008181957A1

    专利类型

  • 公开/公告日2008-07-31

    原文格式PDF

  • 申请/专利权人 MIN WEI;SHUQIAN XU;ANDREW C. LAM;

    申请/专利号US20070767393

  • 发明设计人 ANDREW C. LAM;MIN WEI;SHUQIAN XU;

    申请日2007-06-22

  • 分类号A61K9/14;A61K31/445;

  • 国家 US

  • 入库时间 2022-08-21 20:13:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号